New 10-year data from the DANAMI-3-PRIMULTI trial show long-term benefits of complete revascularization for patients with ...

CABG surgery has been considered the optimal revascularization strategy for patients with diabetes mellitus who have left main and/or multivessel coronary artery disease. The results of a new ...

Perfuze, a medical device company developing catheter technology for interventional stroke care, today announced positive ...

Introduction ADAPT (a direct aspiration first pass technique) has been shown to be fast, cost-effective, and associated with excellent angiographic and clinical outcomes in the treatment of acute ...

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

SAN FRANCISCO -- Age of menarche may provide several insights on long-term cardiometabolic and reproductive health, a ...

A secondary analysis of a large trial shows that exposure to the HIV drug abacavir is linked to an elevated risk for major ...

Why do rural adults and racial and ethnic minorities with vascular disease get major leg amputations more often? A new study ...

Multifaceted Mechanisms and Future of Diabetic Wound Healing and the rapidly evolving subject area, we are pleased to ...

Sirolimus and paclitaxel-coated balloons showed comparable safety and effectiveness in treating CAD across diverse lesion ...

BACKGROUND: Clinical guidelines recommend different revascularization strategies for nonculprit lesions in patients with ST-segment–elevation myocardial infarction (STEMI) versus non-STEMI (NSTEMI).

Cardiogenic shock (CS) is the most common cause of death for patients hospitalized with acute myocardial infarction (MI).